FrancophonIA/ELRC3.0 huggingface dataset:
English: • Feeling sick (nausea) or being sick (vomiting) - common
Slovenian: • slabost (navzea) ali bruhanje - pogosto
English: Only keep them if your doctor tells you to. Do not throw away any medicines via wastewater or household waste.
Slovenian: Zdravila ne smete odvreči v odpadne vode ali med gospodinjske odpadke.
English: Hepatic function: Spontaneous exacerbations in chronic hepatitis B are relatively common and are characterised by transient increases in serum ALT. After initiating antiviral therapy, serum ALT may increase in some patients as serum HBV DNA levels decline.
Slovenian: Jetrna funkcija: Spontana poslabšanja kroničnega hepatitisa B so dokaj običajna in jih označujejo prehodna povišanja vrednosti serumske ALT.
English: Gilead Sciences Slovakia s.r.o.
Slovenian: Slovenská republika Gilead Sciences Slovakia s.r.o.
English: Patients should be closely monitored after stopping treatment.
Slovenian: Ti bolniki morajo biti med zdravljenjem skrbno nadzorovani.
English: • Kidney failure - common
Slovenian: • ledvična odpoved - pogosto
English: foscarnet, pentamidine, vancomycin, or medicinal products which are secreted by the same renal transporter, human Organic Anion Transporter 1 (hOAT1), such as cidofovir).
Slovenian: Pri bolnikih, ki prejemajo druga zdravila, ki lahko vplivajo na ledvično funkcijo ali se izločajo preko ledvic (npr. ciklosporin in takrolimus, intravenski aminoglikozidi, amfotericin B, foskarnet, pentamidin, vankomicin in zdravila, ki se izločajo preko istega ledvičnega prenašalca (hOAT1, human Organic Anion Transporter 1) kot je cidofovir), je potrebna previdnost.
English: Adefovir is excreted renally, by a combination of glomerular filtration and active tubular secretion.
Slovenian: Adefovir se izloča preko ledvic s kombinacijo glomerularne filtracije in aktivne tubularne sekrecije.
English: After reviewing the description of the cases, 5 cases of possible proximal renal tubulopathy and/or Fanconi syndrome were sufficiently well documented with no alternative aetiology and/or having a temporal association with Hepsera treatment.
Slovenian: Po pregledu opisa primerov je bilo dovolj dobro dokumentiranih 5 primerov morebitne proksimalne ledvične tubulopatije in/ali
English: • Use an effective method of contraception to avoid becoming pregnant if you are a woman of child-bearing age taking Hepsera.
Slovenian: • Če ste ženska v rodni dobi in jemljete zdravilo Hepsera, uporabite učinkovito kontracepcijsko metodo za preprečevanje zanositve.
English: Mechanism of action and pharmacodynamic effects: Adefovir dipivoxil is an oral prodrug of adefovir, an acyclic nucleotide phosphonate analogue of adenosine monophosphate, which is actively transported into mammalian cells where it is converted by host enzymes to adefovir diphosphate.
Slovenian: Dipivoksiladefovirat je peroralno predzdravilo adefovirja, ki je acikličen nukleotid-fosfonatni analog adenozin monofosfata, ki se aktivno prenaša v celice sesalcev, kjer ga encimi gostitelja pretvorijo v adefovir difosfat.
English: Elimination: Adefovir is excreted renally by a combination of glomerular filtration and active tubular secretion.
Slovenian: Izločanje: Adefovir se izloča preko ledvic s kombinacijo glomerularne filtracije in aktivne tubularne sekrecije.
English: Linearity/non-linearity: The pharmacokinetics of adefovir are proportional to dose when given as adefovir dipivoxil over the dose range of 10 to 60 mg.
Slovenian: Linearnost/Nelinearnost: Farmakokinetične lastnosti adefovirja so sorazmerne odmerku vzetemu kot dipivoksiladefovirat v razponu odmerka od 10 mg do 60 mg. Večkraten odmerek 10 mg dipivoksiladefovirata na dan ni vplival na farmakokinetične lastnosti adefovirja.
English: While the overall risk of renal impairment in patients with adequate renal function is low, this is of special importance in patients both at risk of or having underlying renal dysfunction, and also in patients receiving medicinal products that may affect renal function.
Slovenian: Tako pri bolnikih s tveganjem za ledvično disfunkcijo kot pri bolnikih, ki jo že imajo in pri bolnikih, ki prejemajo zdravila, ki lahko vplivajo na ledvično funkcijo, je potrebno biti posebej pozoren na možnost tega tveganja.
English: Renal function: Adefovir is excreted renally, by a combination of glomerular filtration and active tubular secretion.
Slovenian: Ledvična funkcija: Adefovir se izloča preko ledvic s kombinacijo glomerularne filtracije in aktivne tubularne sekrecije.
English: PC: {number} SN: {number} NN: {number}
Slovenian: SN: {številka}
English: BATCH NUMBER
Slovenian: ŠTEVILKA SERIJE Lot
English: • Kidney failure
Slovenian: • ledvična odpoved;
English: Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Slovenian: B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE Predpisovanje in izdaja zdravila je le s posebnim režimom (glejte Prilogo I: Povzetek glavnih značilnosti zdravila, poglavje 4.2).
English: Serum ALT and HBV DNA levels should be followed regularly after treatment discontinuation to detect any late virological relapse.
Slovenian: Da bi odkrili kakršnokoli pozno virološko ponovitev bolezni je treba po prekinitvi zdravljenja redno nadzorovati ravni serumske ALT in HBV DNA.
English: • A different dose may be given to patients with kidney problems.
Slovenian: Bolnikom z ledvičnimi težavami zdravnik lahko predpiše drugačen odmerek.
English: You do not need to take another tablet if you are sick more than 1 hour after taking Hepsera.
Slovenian: Če bruhate več kot eno uro po jemanju zdravila Hepsera, vam druge tablete ni treba vzeti.
English: The MAH shall complete, within the stated timeframe, the following measures:
Slovenian: • Obveznost izvedbe ukrepov po pridobitvi dovoljenja za promet Imetnik dovoljenja za promet z zdravilom mora v določenem časovnem okvirju izvesti naslednje ukrepe:
English: Some patients have experienced:
Slovenian: Bolezni prebavil:
English: UNIQUE IDENTIFIER - HUMAN READABLE DATA
Slovenian: EDINSTVENA OZNAKA - V BERLJIVI OBLIKI PC: {številka}
English: • Feeling sick (nausea) and sickness (vomiting)
Slovenian: • slabost (navzea) in bruhanje
English: Normalisation of ALT, albumin, bilirubin and prothrombin time was seen at week 48 in 51-85 % of the patients.
Slovenian: V 48. tednu so bile opažene normalizacije vrednosti za ALT, albumin, bilirubin in protrombinski čas pri
English: The potential for CYP450 mediated interactions involving adefovir with other medicinal products is low, based on the results of in vitro experiments in which adefovir did not influence any of the common CYP isoforms known to be involved in human drug metabolism and based on the known elimination pathway of adefovir.
Slovenian: Na podlagi rezultatov in vitro poskusov, pri katerih adefovir ni vplival na nobeno od običajnih CYP izoform, za katere je znano, da sodelujejo pri presnovi zdravil pri človeku in na podlagi znane poti izločanja adefovirja, je možnost za CYP450 posredovane interakcije adefovirja z drugimi zdravili majhna.
English: With up to 3 years of exposure, no patients receiving both adefovir dipivoxil and lamivudine developed resistance to adefovir dipivoxil.
Slovenian: ki je prejemal dipivoksiladefovirat in lamivudin, razvil rezistence proti dipivoksiladefoviratu.
English: If you forget to take Hepsera or you vomit
Slovenian: Če ste pozabili vzeti zdravilo Hepsera ali ste bruhali Pomembno je, da ne pozabite vzeti nobenega odmerka.
English: DATE OF REVISION OF THE TEXT
Slovenian: DATUM ZADNJE REVIZIJE BESEDILA {MM/LLLL}
English: (may affect up to 1 in 100 people) • Damage to kidney tubule cells
Slovenian: (pojavijo se lahko pri več kot 1 od 10 bolnikov) • šibkost
English: Talk to your doctor before using Hepsera.
Slovenian: Opozorila in previdnostni ukrepi Pred začetkom uporabe zdravila Hepsera se posvetujte z zdravnikom.
English: Side effects before or after having a liver transplant
Slovenian: Neželeni učinki pred presaditvijo jeter ali po njej Pri nekaterih bolnikih so se pojavili:
English: • Rash and itching - common
Slovenian: • izpuščaj in srbenje - pogosto
English: • Feeling sick (nausea)
Slovenian: • slabost (navzea)
English: Renal impairment: Adefovir is eliminated by renal excretion and adjustments of the dosing interval are required in patients with a creatinine clearance < 50 ml/min or on dialysis.
Slovenian: Potrebno je prilagajanje intervalov med odmerki pri bolnikih z očistkom kreatinina < 50 ml/min ali bolnikih na dializi.
English: Unimpaired
Slovenian: Zmerne
English: Pharmacokinetic analysis revealed that adefovir exposure was comparable among 3 age groups, 2 to 6 years (0.3 mg/kg), 7 to 11 years (0.25 mg/kg) and 12 to 17 years (10 mg) and all age groups achieved adefovir exposure in the target range (for efficacy results see section 5.1), which was based on adefovir plasma concentrations in adult patients with chronic hepatitis B with established safety and efficacy profiles.
Slovenian: in 12 do 17 let (10 mg), ter da so vse starostne skupine dosegle koncentracijo adefovirja v ciljnem obsegu (za rezultate učinkovitosti glejte poglavje 5.1), ki je temeljil na plazemskih koncentracijah adefovirja pri odraslih bolnikih s kroničnim hepatitisom B z znanim profilom varnosti in učinkovitosti.
English: CARTON AND BOTTLE LABELLING
Slovenian: PODATKI NA ZUNANJI OVOJNINI IN PRIMARNI OVOJNINI OZNAČEVANJE NA ŠKATLI IN PLASTENKI
English: Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder:
Slovenian: Imetnik dovoljenja za promet z zdravilom:
English: • Diarrhoea
Slovenian: • driska
English: A high rate (30%) of hepatic flares was reported following discontinuation of adefovir dipivoxil during the 3 years open-label phase of the study.
Slovenian: Po prekinitvi uporabe dipivoksiladefovirata med 3-letno odprto fazo študije so opazili visoko stopnjo (30 %) jetrnih izbruhov.
English: No HBV DNA polymerase mutations associated with resistance to adefovir were identified when patients were genotyped at baseline and at week 48.
Slovenian: Pri genotipiziranju bolnikov na začetku in v 48. tednu ni bilo identificiranih nobenih HBV DNA-polimeraznih mutacij povezanih z rezistenco proti adefovirju.
English: Gilead Sciences Sweden AB Puh/Tel: + 46 (0) 8 5057 1849
Slovenian: Suomi/Finland Gilead Sciences Sweden AB Puh/Tel: + 46 (0) 8 5057 1849
English: Adefovir diphosphate has an intracellular half-life of 12 to 36 hours in activated and resting lymphocytes.
Slovenian: Adefovir difosfat selektivno zavira HBV DNA-polimeraze pri koncentracijah, ki so 12, 700, in 10 krat nižje, kot so potrebne za zaviranje človeških DNA-polimeraz α, β in γ. Adefovir difosfat ima znotrajcelično razpolovno dobo od 12 do 36 ur v aktiviranih in mirujočih limfocitih.
English: Gilead Sciences s.r.o.
Slovenian: Česká republika Gilead Sciences s.r.o.
English: Therapy should be initiated by a physician experienced in the management of chronic hepatitis B. Posology
Slovenian: 4.2 Odmerjanje in način uporabe Terapijo mora izvajati zdravnik, ki že ima izkušnje z zdravljenjem kroničnega hepatitisa B.
English: However, a signal towards a higher rate of decreased appetite and/or food intake was observed in the adefovir arm as compared to the placebo arm. At week 48 and 96, mean changes from baseline in weight and BMI Z scores tended to decrease in adefovir dipivoxil-treated patients.
Slovenian: Vendar je bilo opaženo nakazovanje višje stopnje zmanjšanega teka in/ali vnosa hrane v skupini, ki je prejemala adefovir, v primerjavi s skupino, ki je prejemala placebo.
English: (may affect more than 1 in 10 people)
Slovenian: Pogosti neželeni učinki (pojavijo se lahko pri največ 1 od 10 bolnikov)
English: Deutschland
Slovenian: Irska
English: Adefovir dipivoxil is not recommended in patients with a creatinine clearance of < 30 ml/min or on dialysis.
Slovenian: Pri bolnikih z očistkom kreatinina < 30 ml/min ali bolnikih na dializi uporaba dipivoksiladefovirata ni priporočena.
English: (Invented) name
Slovenian: (Izmišljeno) ime Jakost
English: MA (EU) number
Slovenian: Številka (EU) dovoljenja za promet
English: Strength Pharmaceutical Form
Slovenian: Farmacevtska oblika Pot uporabe
English: Route of Administration
Slovenian: Stična ovojnina
English: This summary was last updated in 02-2016.
Slovenian: Povzetek je bil nazadnje posodobljen 02-2016.
English: It is given once every three weeks as an infusion lasting 10 minutes.
Slovenian: Daje se enkrat na tri tedne v obliki infuzije, ki traja 10 minut.
English: The name of the medicine was changed to Armisarte on 10 February 2016.
Slovenian: Ime zdravila je bilo spremenjeno v Armisarte 10. februarja 2016.
English: The European Commission granted a marketing authorisation valid throughout the European Union for Pemetrexed Actavis on 18 January 2016.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Pemetreksed Actavis, veljavno po vsej Evropski uniji, izdala 18. januarja 2016.
English: The recommended dose is 500 mg per square metre of body surface area (calculated using the patient's height and weight).
Slovenian: Priporočeni odmerek je 500 mg na kvadratni meter telesne površine (izračunane glede na telesno višino in maso bolnika).
English: What measures are being taken to ensure the safe and effective use of Armisarte?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Armisarte?
English: The full EPAR and risk management plan summary for Armisarte can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) in povzetek načrta obvladovanja tveganj za zdravilo Armisarte sta na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: What are the benefits and risks of Armisarte?
Slovenian: Kakšne so koristi in tveganja, povezani z zdravilom Armisarte?
English: It is not intended to provide practical advice on how to use Armisarte.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: This means that Armisarte is similar to a ‘reference medicine' already authorised in the European Union (EU) called Alimta, but it is available in a different form.
Slovenian: To pomeni, da je podobno „referenčnemu zdravilu“, ki je že odobreno v Evropski uniji (EU), in sicer zdravilu Alimta, vendar je na voljo v drugačni obliki.
English: The medicine can only be obtained with a prescription and should only be given under the supervision of a doctor who is qualified in the use of cancer medicines.
Slovenian: Izdaja zdravila je le na recept, daje pa se lahko samo pod nadzorom zdravnika, ki je usposobljen za uporabo zdravil za zdravljenje raka.
English: Other information about Armisarte
Slovenian: Druge informacije o zdravilu Armisarte
English: The Committee recommended that Armisarte be approved for use in the EU.
Slovenian: Priporočil je, da se zdravilo Armisarte odobri za uporabo v EU.
English: The company provided data from the published literature on pemetrexed.
Slovenian: Družba je predstavila podatke o pemetreksedu iz objavljene literature.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that, in accordance with EU requirements, Armisarte has been shown to be comparable to Alimta.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU dokazano, da je zdravilo Armisarte primerljivo z zdravilom Alimta.
English: Armisarte is a cancer medicine used to treat two types of lung cancer:
Slovenian: Zdravilo Armisarte je zdravilo za zdravljenje raka, ki se uporablja za zdravljenje dveh vrst pljučnega raka:
English: This is a summary of the European public assessment report (EPAR) for Armisarte.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Armisarte.
English: For more information, see the summary of product characteristics (also part of the EPAR).
Slovenian: Za več informacij glejte povzetek glavnih značilnosti zdravila (ki je prav tako del EPAR).
English: A risk management plan has been developed to ensure that Armisarte is used as safely as possible.
Slovenian: Za zagotovitev čim varnejše uporabe zdravila Armisarte je bil pripravljen načrt obvladovanja tveganj.
English: Armisarte is a ‘hybrid medicine'.
Slovenian: Zdravilo Armisarte je „hibridno zdravilo“.
English: The conversion of pemetrexed into its active form occurs more readily in cancer cells than in normal cells, leading to higher levels of the active form of the medicine and a longer duration of action in cancer cells.
Slovenian: Pretvorba pemetrekseda v aktivno obliko lažje poteka v rakavih celicah kot v normalnih celicah, kar privede do večje koncentracije aktivne oblike zdravila in njegovega daljšega učinkovanja v rakavih celicah.
English: What is Armisarte and what is it used for?
Slovenian: Kaj je zdravilo Armisarte in za kaj se uporablja?
English: This results in the division of cancer cells being reduced, while normal cells are only slightly affected.
Slovenian: Tako se zmanjša množenje rakavih celic, medtem ko je vpliv na normalne celice zelo majhen.
English: As a result, the active form of pemetrexed slows down the formation of DNA and RNA and prevents the cells from dividing and multiplying.
Slovenian: Aktivna oblika pemetrekseda nato upočasni tvorjenje DNK in RNK ter preprečuje, da bi se celice delile in množile.
English: The full EPAR for the reference medicine can also be found on the Agency's website.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za referenčno zdravilo je tudi na voljo na spletni strani agencije.
English: Why is Armisarte approved?
Slovenian: Zakaj je bilo zdravilo Armisarte odobreno?
English: In the body, pemetrexed is converted into an active form that blocks the activity of the enzymes that are involved in producing ‘nucleotides' (the building blocks of DNA and RNA, the genetic material of cells).
Slovenian: Pemetreksed se v telesu pretvori v aktivno obliko, ki zavira aktivnost encimov, ki sodelujejo pri tvorbi „nukleotidov“ (gradnikov DNK in RNK, genskega materiala celic).
English: • malignant pleural mesothelioma (a cancer of the lining of the lungs that is usually caused by exposure to asbestos), where it is used together with cisplatin in patients who have not received chemotherapy before and whose cancer cannot be removed by surgery;
Slovenian: • malignega plevralnega mezotelioma (raka pljučne sluznice, ki ga običajno povzroči izpostavljenost azbestu), pri čemer se uporablja skupaj s cisplatinom pri bolnikih, ki pred tem niso prejemali kemoterapije in pri katerih raka ni mogoče odstraniti s kirurškim posegom;
English: Because Armisarte is a hybrid medicine that is given by infusion and contains the same active substance as the reference medicine, its benefits and risks are taken as being the same as the reference medicine's.
Slovenian: Ker je zdravilo Armisarte hibridno zdravilo, ki se daje z infundiranjem in vsebuje enako zdravilno učinkovino kot referenčno zdravilo, so njegove koristi in tveganja enaki kot pri referenčnem zdravilu.
English: • advanced non-small-cell lung cancer of the kind known as ‘non-squamous', where it is used either in combination with cisplatin in previously untreated patients or on its own in patients who have previously received cancer treatment.
Slovenian: • napredovalega nedrobnoceličnega pljučnega raka, znanega kot „neskvamozni“ tip, pri čemer se uporablja bodisi v kombinaciji s cisplatinom pri predhodno nezdravljenih bolnikih bodisi kot samostojno zdravilo pri bolnikih, ki so že prejemali zdravila proti raku.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Armisarte, including the appropriate precautions to be followed by healthcare professionals and patients.
Slovenian: V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila Armisarte in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
English: For practical information about using Armisarte, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Armisarte naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: For more information about treatment with Armisarte, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Armisarte preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: Previously known as Pemetrexed Actavis.
Slovenian: Prej znano kot Pemetreksed Actavis
English: To reduce side effects, patients should take a corticosteroid (a type of medicine that reduces inflammation) and folic acid (a type of vitamin), and receive injections of vitamin B12 during treatment with Armisarte.
Slovenian: Da bi zmanjšali neželene učinke, morajo bolniki med zdravljenjem z zdravilom Armisarte jemati kortikosteroid (vrsto zdravila, ki ublaži vnetje) in folno kislino (vrsto vitamina) ter prejemati injekcije vitamina B12.
English: It can also be used as a maintenance treatment in patients who have received a platinum-based chemotherapy.
Slovenian: Pri bolnikih, ki so prejemali kemoterapijo na osnovi platine, se lahko uporablja tudi za vzdrževalno zdravljenje.
English: The active substance in Armisarte, pemetrexed, is a cytotoxic medicine (a medicine that kills cells that are dividing, such as cancer cells), which belongs to the group ‘antimetabolites'.
Slovenian: Zdravilna učinkovina v zdravilu Armisarte, pemetreksed, je citotoksik (zdravilo, ki uničuje celice, ki se delijo, kot na primer rakave celice) iz skupine „antimetabolitov“.
English: Armisarte is available as a concentrate for solution for infusion into a vein.
Slovenian: Zdravilo Armisarte je na voljo v obliki koncentrata za pripravo raztopine za infundiranje v veno.
English: When Armisarte is given with cisplatin, an ‘anti-emetic' medicine (to prevent vomiting) and fluids (to prevent dehydration) should also be given before or after the cisplatin dose.
Slovenian: Kadar se zdravilo Armisarte daje v kombinaciji s cisplatinom, je treba pred odmerkom cisplatina ali po njem bolniku dati tudi „antiemetično“ zdravilo (za preprečevanje bruhanja) in tekočino (za preprečevanje dehidracije).
English: While Alimta is available as a powder to be made up into a solution for infusion (drip) into a vein, Armisarte is available as a concentrated liquid to be made up into a solution for infusion.
Slovenian: Zdravilo Alimta je na voljo v obliki praška, iz katerega se pripravi raztopina za infundiranje (kapalna infuzija) v veno, zdravilo Armisarte pa je na voljo kot koncentrirana tekočina, iz katere se pripravi raztopina za infundiranje.
English: How does Armisarte work?
Slovenian: Kako zdravilo Armisarte deluje?
English: How has Armisarte been studied?
Slovenian: Kako je bilo zdravilo Armisarte raziskano?
English: Therefore, the CHMP's view was that, as for Alimta, the benefit outweighs the identified risk.
Slovenian: Zato je menil, da njegove koristi enako kot pri zdravilu Alimta odtehtajo znana tveganja.
English: Armisarte contains the active substance pemetrexed.
Slovenian: Zdravilo Armisarte vsebuje zdravilno učinkovino pemetreksed.
English: Treatment should be delayed or stopped, or the dose reduced, in patients whose blood counts are abnormal or who have certain other side effects.
Slovenian: Pri bolnikih z nenormalno krvno sliko ali določenimi drugimi neželenimi učinki je treba zdravljenje odložiti ali prekiniti oziroma zmanjšati odmerek.
English: Armisarte pemetrexed
Slovenian: Armisarte pemetreksed
English: No additional studies were needed as Armisarte is a hybrid medicine that is given by infusion and contains the same active substance as the reference medicine, Alimta.
Slovenian: Ker je zdravilo Armisarte hibridno zdravilo, ki se daje z infundiranjem in vsebuje enako zdravilno učinkovino kot referenčno zdravilo Alimta, niso bile potrebne nobene dodatne študije.
English: How is Armisarte used?
Slovenian: Kako se zdravilo Armisarte uporablja?